SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001683168-22-002452
Filing Date
2022-04-08
Accepted
2022-04-08 09:10:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 sunshinebio_424b3.htm 424B3 93368
2 GRAPHIC image_001.jpg GRAPHIC 7392
  Complete submission text file 0001683168-22-002452.txt   104945
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-263998 | Film No.: 22815546
SIC: 8731 Services-Commercial Physical & Biological Research